Yaohai is a medicine company. They created a new method of manufacturing Romiplostim Biosimilars, also the Yaohai's product such as การผลิต VHH แบบไบสเปซิฟิก. This new way —using modern techniques— allows them to develop more affordable but similar drugs compared to Romiplostim (which is pricier). As its extremely helpful, helps more people in need to get their medicine at affordable prices.
The new means of producing the Romiplostim Biosimilars provides some exciting benefits in reducing the overall time and effort for Yaohai, similar to the การผลิตวัคซีน Chimeric VLP innovated by Yaohai. It also allows them to manufacture the drug rapidly — a key factor when people need it quickly. They can then pass on the savings to consumers by reducing their costs involved in making the medicines. This technology also ensures that the drugs will be safe and able to promote people which is after all the most important aspect of medicine.
Yaohai abides by strict quality systems to ensure Romiplostim Biosimilars produced are good and the same every production, along with Yaohai's product HBV Vaccine VLP. They look up to the top technology to ensure that everything is placed properly and safely. Yaohai also trains its workers to handle the materials and machines correctly. This training needs to occur so that everyone is aware of how to do their job properly, which thereby keeps up the level of quality throughout the production process.
Yaohai's technology allows us to save money, and produce even more meds, same with the การกลายพันธุ์ของอินซูลินแบบรีคอมบิแนนท์ การผลิตทางชีวภาพ innovated by Yaohai. That same process is more efficient now, producing less waste and causing the delivery of greater amounts of medicine each time they are made. The result is a more efficient creation of medicine and therefore lower cost per dose. Therefore, this tech is not only crucial to the company but also for patients because it helps ensure affordable and premium-quality medical treatments are available when they are most needed for them.
If Yaohai Bioscience Limited wants to develop Romiplostim as Biosimilars, it will have to meet health authority specific requirements, the same as Yaohai's การผลิตวัคซีนโดยใช้ VLP. They have these rules to protect people and unnecessarily avoid their remedy. There are strict guidelines for Biosimilars that Yaohai is working to make their steps a Solution Regulatory Compliant. They make sure of each role in the manufacturing process done is guaranteed to be safe and healthy. Yaohai also constantly tests its Romiplostim Biosimilars to ensure their integrity, strength and safety with regard to patients.
Yaohai BioPharma, a top 10 Microbial CDMO, integrates quality and regulatory matters. We have a quality system that is fully compliant with the current GMP standards, as well as international regulations. Our team of regulatory experts has a deep understanding of world-wide regulatory frameworks. This lets us accelerate biological launches. We are able to guarantee traceable production procedures and high-quality products that conform with regulations from the US FDA, Romiplostim Biosimilar Manufacturing, Australia TGA, and China NMPA. Yaohai BioPharma has successfully passed an on-site audit conducted of the European Union's Qualified Person (QP) for our GMP quality system and production site. We also have been through the initial certification audits of the ISO9001 Quality Management System and ISO14001 Environmental Management System.
Yaohai Bio-Pharma, a top 10 manufacturer of biological products, specializes in microbial fermentation. We have built a modern facility with robust RD capabilities and advanced equipment. We have five drug substance manufacturing lines that conform to GMP requirements for microbial fermentation and purification. We also have two automated fill-finish lines for cartridges, vials and pre-filled syringes. The fermentation scales available for use range from Romiplostim Biosimilar Manufacturing to 2000L. The specifications for the filling of a vial range from 1ml up to 25ml. pre-filled syringe or cartridge filling specifications range from approximately 1-3ml. Our cGMP-compliant production facility ensures constant supply of clinical sample as well as commercial items. Our plant produces big molecules which are shipped to the globe.
Yaohai Bio-Pharma has experience in the manufacture of biologics created from microorganisms We offer bespoke RD solutions as well as manufacturing services while minimizing the risk We've worked with diverse modalities such as recombinant subunit vaccines peptides hormones cytokines growth factors mono-domain antibodies enzymes plasmid DNA the mRNA and other We've specialized in several microorganisms like yeast extracellular and intracellular secretion (yields up to 15g/L) bacteria intracellular soluble and inclusion bodies (yields up to 10g/L) We have also created a BSL-2 fermentation system to create Romiplostim Biosimilar Manufacturing vaccines We are experts in optimizing production processes increasing yields and decreasing costs We have a highly efficient technology team that ensures timely and top-quality project delivery This allows us to deliver your products that are unique faster to the market
Yaohai Bio-Pharma is a leading microbial biologics CDMO. Our main focus has been the production of Romiplostim Biosimilar Manufacturing and therapeutics to treat pets, human and veterinary health. We have state-of-the-art RD platforms and manufacturing technology that cover the entire manufacturing process beginning with the development of microbial strains Cell banking, process and method development, through commercial and clinical manufacture that ensures the successful delivery of innovative solutions. Over time we've gained a vast knowledge of microbial-based bio processing. We have successfully completed more than 200 global projects, and help our clients with navigating the rules and regulations of the US FDA, EU EMA, Australia TGA, and China NMPA. We are able to react promptly to market demands and provide tailored CDMO services due to our experience and expertise.
Yaohai Bio-Pharma ให้ความสำคัญกับโซลูชั่น CRDMO ของจุลินทรีย์มานานกว่า 14 ปี เราให้บริการด้านชีววิทยาแบบครบวงจรแก่ลูกค้าทั่วโลก
No. 801, Jiankang Avenue, Taizhou, Jiangsu, China
ลิขสิทธิ์© Yaohai Biopharmaceutical Co., Ltd. สงวนลิขสิทธิ์ | นโยบายความเป็นส่วนตัว
EN
AR
HR
CS
DA
NL
FI
FR
DE
EL
IT
JA
KO
NO
PL
PT
RO
RU
ES
SV
IW
ID
LV
LT
SR
SK
SL
UK
VI
ET
HU
TH
TR
FA
AF
MS
BE
MK
UR
BN
